Managing and Reducing Uncertainty in an Emerging Influenza Pandemic
Open Access
- 9 July 2009
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 361 (2) , 112-115
- https://doi.org/10.1056/nejmp0904380
Abstract
The early phases of an epidemic present decision makers with predictable challenges1 that have been evident as the current novel influenza A (H1N1) virus has spread. The scale of the problem is uncertain when a disease first appears but may increase rapidly. Early action is required, but decisions about action must be made when the threat is only modest — and consequently, they involve a trade-off between the comparatively small, but nearly certain, harm that an intervention may cause (such as rare adverse events from large-scale vaccination or economic and social costs from school dismissals) and the uncertain probability of much greater harm from a widespread outbreak. This combination of urgency, uncertainty, and the costs of interventions makes the effort to control infectious diseases especially difficult.Keywords
This publication has 4 references indexed in Scilit:
- Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009.2009
- Deaths from Bacterial Pneumonia during 1918–19 Influenza PandemicEmerging Infectious Diseases, 2008
- Epidemiologic Characterization of the 1918 Influenza Pandemic Summer Wave in Copenhagen: Implications for Pandemic Control StrategiesThe Journal of Infectious Diseases, 2008
- Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a Smoldering PandemicThe Journal of Infectious Diseases, 2005